Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy
This study is ongoing, but not recruiting participants.
Study NCT00426348   Information provided by Guangdong General Hospital

First Received on January 23, 2007.   Last Updated on January 6, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Glomerulonephritis
IGA Nephropathy
Additional conditions recognized in this trial
Glomerulonephritis, IGA
Kidney Diseases
More general conditions related to this trial
Autoimmune Diseases
Immune System Diseases
Nephritis
Urologic Diseases
Interventions listed in this trial
Valsartan
Probucol
Placebo
Additional drug interventions recognized in this trial
Antioxidants
More general drug interventions related to this trial
Angiotensin II Type 1 Receptor Blockers
Angiotensin Receptor Antagonists
Anticholesteremic Agents
Antihypertensive Agents
Antimetabolites
Cardiovascular Agents
Hypolipidemic Agents
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Guangdong General Hospital


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services